Neurogene (NGNE) - Kompaniyaning xususiy kapitali

Ommaviy kompaniya Neurogene (NGNE) logotipi

Neurogene Inc. (NGNE) noyob miya patologiyalari uchun innovatsion gen terapiyasi usullarini ishlab chiqishga ixtisoslashgan bo'lib, neyrogenetika bozorini va Rett sindromi bilan kasallangan bemorlarni nishonga oladi. Olimlar va investorlar orasidagi yuqori nufuzi uning istiqbolli ishlab chiquvchi sifatidagi maqomini tasdiqlaydi. Ushbu kunlik narxlar grafigi indikator 0.27 darajasida turgan kotirovkalarni aks ettiradi. Biroq, klinik sinovlar davomidagi potentsial muvaffaqiyatsizliklar va cheklangan iste'molchilar bazasi jiddiy tahdidlarni ifodalaydi.

NGNE Neurogene Balans kapitallashuvi (21.02.2024 - 28.10.2026)

Neurogene (NGNE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Neurogene Therapeutics|NGNE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Neurogene Inc|NGNE - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Neurogene|NGNE - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti neurogene.com|NGNE - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Neurogene Inc.|NGNE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Neurogene Inc|NGNE - Kompaniya qarzlari|Balans qiymatiga qarzlar Neurogene Inc
Kompaniyaning jamlanma tahlili:Neurogene Therapeutics - NGNE
Neurogene Inc yetakchi tovari

Aktivlarning qiyosiy tahlili kapitalning real tannarxini bozor kotirovkalariga nisbatan baholashni talab qiladi. Ushbu metrika SEC hisobot ma'lumotlari orqali narxlarning tebranishlarini yumshatgan holda, sof kapital qiymatini o'lchaydi. AQSh huquqiy bazasining barqarorligi va Neurogene Inc. (NGNE) ishlanmalarining gumanitar maqomi ushbu bazaga tegishli tashqi risklarni minimallashtiradi. Investorlar uchun narxning fundamental asosdan chetlashishini kuzatish juda muhimdir. Kompaniyaga tegishli balans kapitalining joriy miqdori kirish nuqtalarini aniqlash uchun aniq mezon bo'lib xizmat qiladi.

Asosiy raqobatchilar

BIIB - Buxgalteriya kapitallashuvi|Balans kapitallashuvi NBIX|RGC (regencellbioscience.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Trevi Therapeutics (TRVI)|Buxgalteriya kapitallashuvi praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CeriBell Inc CBLL|Kompaniyaning sof aktivlari PRTA (prothena.com)|Alector Inc. - Balans kapitallashuvi|Kompaniyaning balans qiymati Annexon, Inc. (ANNX)|OMER: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati ACIU|Voyager Therapeutics Inc (VYGR) - Kompaniyaning xususiy kapitali|Neumora Therapeutics Inc - Balans kapitallashuvi|Biznesning balans qiymati Scilex Holding Company, Inc.|Tevogen Bio Holdings - Balans kapitallashuvi|Kompaniyaning xususiy kapitali ACOG (alphacognition.com)|CGTX - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi Inhibikase Therapeutics Inc IKT|SAVA (Cassava) - Balans kapitallashuvi|Assertio Holdings, Inc. (ASRT) - Kompaniyaning xususiy kapitali|Kompaniyaning sof aktivlari coyatherapeutics.com COYA|Vistagen (VTGN) - Kompaniyaning buxgalteriya qiymati|OVID: Balans kapitallashuvi|Biznesning balans bahosi ABOS|Kompaniyaning balans qiymati CervoMed Inc CRVO|Buxgalteriya kapitallashuvi alteritytherapeutics.com (ATHE)|Clene - Balans kapitallashuvi|PEPG - Kompaniyaning sof aktivlari|Kompaniyaning sof aktivlari JUNS (Jupiter Neurosciences Inc)|RLMD: Biznesning balans bahosi|Kompaniyaning balans qiymati Annovis Bio Corp|Grace Therapeutics (GRCE) - Buxgalteriya kapitallashuvi|Firefly Neuroscience, Inc - Balans kapitallashuvi|Biznesning balans qiymati KLTO|Kompaniyaning balans qiymati NeuroSense Therapeutics NRSN|Buxgalteriya kapitallashuvi Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Balans kapitallashuvi|NeurAxis Inc - Kompaniyaning xususiy kapitali|Helius Medical Technologies Inc. (HSDT) - Kompaniyaning balans qiymati|PASG - Buxgalteriya kapitallashuvi|Balans kapitallashuvi NEUP|Kompaniyaning xususiy kapitali Minerva Neurosciences Inc|ATHA (Athira) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ADXN|Alzamend Neuro, Inc. (ALZN) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati CYCN (cyclerion.com)|PTIX: Kompaniyaning balans qiymati|Pasithea Therapeutics Corp - Kompaniyaning xususiy kapitali|Cortigent Medical (CRGT) - Kompaniyaning balans qiymati|ATXI - Buxgalteriya kapitallashuvi|Balans kapitallashuvi BCLI|Kompaniyaning xususiy kapitali caratherapeutics.com|CHRO (Chromocell Therapeutics Corp.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ELYM|Intra-Cellular Therapies (ITCI) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati LBPH (Longboard)|MRNS: Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali nkgenbiotech.com NKGN|Balans kapitallashuvi NRBO|SAGE - Biznesning balans qiymati|Balans kapitallashuvi SNPX|TRVN (Trevena Inc) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Vigil Neuroscience Inc. (VIGL)|Buxgalteriya kapitallashuvi Anew Medical Inc.|Cerevel Therapeutics, Inc. - Balans kapitallashuvi